Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Feb;114(3):584–591. doi: 10.1111/j.1476-5381.1995.tb17179.x

Regional haemodynamic effects of human and rat adrenomedullin in conscious rats.

S M Gardiner 1, P A Kemp 1, J E March 1, T Bennett 1
PMCID: PMC1510022  PMID: 7735684

Abstract

1. Male, Long Evans rats were chronically instrumented with pulsed Doppler flow probes and intravascular catheters to permit assessment of the regional haemodynamic responses to human and rat adrenomedullin, to compare the responses to human adrenomedullin to those of human alpha-CGRP in the absence and presence of the CGRP1-receptor antagonist, human alpha-CGRP [8-37], and to determine the involvement of nitric oxide (NO)-mediated mechanisms in the responses to human adrenomedullin, relative to human alpha-CGRP. 2. Human and rat adrenomedullin (0.3, 1, and 3 nmol kg-1, i.v.) caused dose-dependent hypotension and tachycardia, accompanied by increases in renal, mesenteric and hindquarters flows and vascular conductances. At the lowest dose only, the hypotensive and mesenteric vasodilator effects of rat adrenomedullin were significantly greater than those of human adrenomedullin. 3. Human alpha-CGRP at a dose of 1 nmol kg-1 caused hypotension, tachycardia and increases in hindquarters flow and vascular conductance, but reduction in renal and mesenteric flows, and only transient vasodilatations in these vascular beds. These effects were substantially inhibited by human alpha-CGRP [8-37] (100 nmol kg-1 min-1), but those of human adrenomedullin (1 nmol kg-1) were not; indeed, the mesenteric haemodynamic effects of the latter peptide were enhanced by the CGRP1-receptor antagonist. 4. In the presence of the NO synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 183 nmol kg-1 min-1), there was only a slight, but significant, inhibition of the hindquarters hyperaemic vasodilator effect of human adrenomedullin, but not that of human alpha-CGRP.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
586

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gardiner S. M., Bennett T. Involvement of nitric oxide in the regional haemodynamic effects of perindoprilat and captopril in hypovolaemic Brattleboro rats. Br J Pharmacol. 1992 Dec;107(4):1181–1191. doi: 10.1111/j.1476-5381.1992.tb13426.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol. 1988 Sep;95(1):197–208. doi: 10.1111/j.1476-5381.1988.tb16565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of human alpha- and beta-calcitonin gene-related peptide in conscious Wistar rats. Br J Pharmacol. 1989 Dec;98(4):1225–1232. doi: 10.1111/j.1476-5381.1989.tb12668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic effects of calcitonin gene-related peptide. Am J Physiol. 1989 Feb;256(2 Pt 2):R332–R338. doi: 10.1152/ajpregu.1989.256.2.R332. [DOI] [PubMed] [Google Scholar]
  5. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T., Bose C., Foulkes R., Hughes B. Antagonistic effect of human alpha-CGRP [8-37] on the in vivo regional haemodynamic actions of human alpha-CGRP. Biochem Biophys Res Commun. 1990 Sep 28;171(3):938–943. doi: 10.1016/0006-291x(90)90774-h. [DOI] [PubMed] [Google Scholar]
  6. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T., Foulkes R., Hughes B. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats. Br J Pharmacol. 1991 May;103(1):1256–1262. doi: 10.1111/j.1476-5381.1991.tb12333.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol. 1990 Nov;101(3):625–631. doi: 10.1111/j.1476-5381.1990.tb14131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gardiner S. M., Kemp P. A., Bennett T., Palmer R. M., Moncada S. Regional and cardiac haemodynamic effects of NG, NG,dimethyl-L-arginine and their reversibility by vasodilators in conscious rats. Br J Pharmacol. 1993 Dec;110(4):1457–1464. doi: 10.1111/j.1476-5381.1993.tb13985.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Han S. P., Naes L., Westfall T. C. Calcitonin gene-related peptide is the endogenous mediator of nonadrenergic-noncholinergic vasodilation in rat mesentery. J Pharmacol Exp Ther. 1990 Nov;255(2):423–428. [PubMed] [Google Scholar]
  10. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994 Jan 24;338(1):6–10. doi: 10.1016/0014-5793(94)80106-1. [DOI] [PubMed] [Google Scholar]
  11. Ishiyama Y., Kitamura K., Ichiki Y., Nakamura S., Kida O., Kangawa K., Eto T. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 1993 Sep 14;241(2-3):271–273. doi: 10.1016/0014-2999(93)90214-3. [DOI] [PubMed] [Google Scholar]
  12. Ishizaka Y., Ishizaka Y., Tanaka M., Kitamura K., Kangawa K., Minamino N., Matsuo H., Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1994 Apr 15;200(1):642–646. doi: 10.1006/bbrc.1994.1496. [DOI] [PubMed] [Google Scholar]
  13. Kawasaki H., Takasaki K., Saito A., Goto K. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature. 1988 Sep 8;335(6186):164–167. doi: 10.1038/335164a0. [DOI] [PubMed] [Google Scholar]
  14. Kitamura K., Ichiki Y., Tanaka M., Kawamoto M., Emura J., Sakakibara S., Kangawa K., Matsuo H., Eto T. Immunoreactive adrenomedullin in human plasma. FEBS Lett. 1994 Mar 21;341(2-3):288–290. doi: 10.1016/0014-5793(94)80474-5. [DOI] [PubMed] [Google Scholar]
  15. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993 Apr 30;192(2):553–560. doi: 10.1006/bbrc.1993.1451. [DOI] [PubMed] [Google Scholar]
  16. Kurtz A., Muff R., Born W., Lundberg J. M., Millberg B. I., Gnädinger M. P., Uehlinger D. E., Weidmann P., Hökfelt T., Fischer J. A. Calcitonin gene-related peptide is a stimulator of renin secretion. J Clin Invest. 1988 Aug;82(2):538–543. doi: 10.1172/JCI113629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lin B., Gao Y., Chang J. K., Heaton J., Hyman A., Lippton H. An adrenomedullin fragment retains the systemic vasodepressor activity of rat adrenomedullin. Eur J Pharmacol. 1994 Jul 21;260(1):1–4. doi: 10.1016/0014-2999(94)90002-7. [DOI] [PubMed] [Google Scholar]
  18. Marshall I., Al-Kazwini S. J., Holman J. J., Craig R. K. Human and rat alpha-CGRP but not calcitonin cause mesenteric vasodilatation in rats. Eur J Pharmacol. 1986 Apr 16;123(2):217–222. doi: 10.1016/0014-2999(86)90662-x. [DOI] [PubMed] [Google Scholar]
  19. Nuki C., Kawasaki H., Kitamura K., Takenaga M., Kangawa K., Eto T., Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun. 1993 Oct 15;196(1):245–251. doi: 10.1006/bbrc.1993.2241. [DOI] [PubMed] [Google Scholar]
  20. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Matsuo H., Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun. 1993 Sep 15;195(2):921–927. doi: 10.1006/bbrc.1993.2132. [DOI] [PubMed] [Google Scholar]
  21. Sugo S., Minamino N., Kangawa K., Miyamoto K., Kitamura K., Sakata J., Eto T., Matsuo H. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1160–1166. doi: 10.1006/bbrc.1994.1827. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES